PE-Labeled Monoclonal Anti-C11D5.3 scFv Antibody, Mouse IgG1 (3G8C1) (0.03% Proclin)
抗體來源(Source)
Monoclonal Anti-C11D5.3 scFv Antibody, Mouse IgG1 (3G8C1) is a non-neutralizing antibody expressed from human HEK293 cells, which provides higher batch consistency and long term security of supply.
應(yīng)用(Application)
Flow Cytometry (Evaluation of Anti-BCMA (C11D5.3 scFv) CAR Expression).
克隆號(Clone)
3G8C1
種屬(Species)
Mouse
亞型(Isotype)
Mouse IgG1 | Mouse kappa
特異性(Specificity)
Specifically recognizes C11D5.3 derived CARs.
免疫原(Immunogen)
Recombinant C11D5.3 scFv derived from HEK293 cell
偶聯(lián)(Conjugate)
PE
Excitation Wavelength: 488 nm / 561 nm
Emission Wavelength: 575 nm
同型對照(Isotype Control)
The isotype control is sold separately; please refer to Cat. No. DNP-PM1 for product information.
推薦稀釋比(Recommended Dilution)
1:50
制劑(Formulation)
Lyophilized from a 0.22 μm-filtered solution in PBS (pH 7.4) containing 0.03% ProClin 300 and 0.2% BSA, with trehalose as protectant.
Please contact us for customized product forms or formulations.
重構(gòu)方法(Reconstitution)
Please refer to the Certificate of Analysis (CoA) for specific instructions.
For best performance, we strongly recommend following the reconstitution protocol provided in the CoA.
存儲(Storage)
Please protect from light and avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 24 months in lyophilized state;
-70°C for 12 months after reconstitution.
2-8 °C for 12 months after reconstitution.

背景介紹
C11D5.3 是一種靶向 BCMA 的 IgG1 小鼠單克隆抗體,而 BCMA 是多發(fā)性骨髓瘤和淋巴瘤免疫治療的靶點(diǎn)。C11D5.3 scFv 是 BCMA 特異性 CAR 中最常用的胞外結(jié)構(gòu)域組分。迄今為止,已報道的多項 CART-BCMA 臨床試驗均包含源自 C11D5.3 的抗 BCMA scFv,例如 FDA 批準(zhǔn)的 CAR 產(chǎn)品 Abecma。
關(guān)鍵字: C11D5.3 scFv抗體;C11D5.3 scFv;Anti-C11D5.3 scFv;百普賽斯;ACRO;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國、美國、瑞士等12個城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。